CONcomitant eValuation of Epicor Left atRial Therapy for AF

NATerminatedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Atrial Fibrillation
Interventions
DEVICE

Epicor LP Cardiac Ablation System

Surgical ablation of permanent AF during concomitant open chest and/or open heart surgery

PROCEDURE

Surgical ablation of permanent AF

Concomitant AF ablation during mitral valve surgery

Trial Locations (15)

11576

St. Francis Hospital, Roslyn

14642

University of Rochester Medical Center, Rochester

21218

Midatlanatic Cardiovascular Associates, PA; Union Memorial Hospital, Baltimore

27710

Duke University Medical Center, Durham

28801

Mission Hospital, Inc, Asheville

32501

Cardiology Consultants, MD's PA (Baptist Hospital), Pensacola

34208

Manatee Memorial Hospital, Bradenton

34209

Blake Medical Center, Bradenton

46321

Community Hospital, Munster

48073

William Beaumont Hospital, Royal Oak

55102

HealthEast St. Joseph's Hospital, Saint Paul

55407

Minneapolis Heart Institute Foundation/Abbott NW Hospital, Minneapolis

60201

NorthShore University Health System, Evanston

93720

St. Agnes Medical Center, Fresno

07601

Hackensack University Medical Center, Hackensack

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00519194 - CONcomitant eValuation of Epicor Left atRial Therapy for AF | Biotech Hunter | Biotech Hunter